Suppr超能文献

在一个对甲状腺激素普遍抵抗的家族中,c-erbAβ甲状腺激素受体密码子315处的精氨酸突变为组氨酸,导致该受体具有显著的3,5,3'-三碘甲状腺原氨酸结合活性。

An arginine to histidine mutation in codon 315 of the c-erbA beta thyroid hormone receptor in a kindred with generalized resistance to thyroid hormones results in a receptor with significant 3,5,3'-triiodothyronine binding activity.

作者信息

Cugini C D, Leidy J W, Chertow B S, Bérard J, Bradley W E, Menke J B, Hao E H, Usala S J

机构信息

Medical Service, Huntington Veterans Administration Medical Center, West Virginia 25704.

出版信息

J Clin Endocrinol Metab. 1992 May;74(5):1164-70. doi: 10.1210/jcem.74.5.1314846.

Abstract

Generalized resistance to thyroid hormones results from diverse mutations in the T3-binding domain of the c-erbA beta thyroid hormone receptor, and different kindreds have variable phenotypes. However, the T3-binding affinities of these mutant receptors studied in vitro have all been severely reduced compared to wild type. We report here a new kindred, CL, with a mutation further upstream than previously reported, a guanine to adenine base substitution at nucleotide 1244 in codon 315 changing an arginine to histidine. This base substitution was the only one found in codons 90-456 of genomic sequence and was formally shown to be a mutation by screening 51 random individuals. The kindred CL receptor complementary DNA was recreated, and the mutant receptor synthesized with rabbit reticulocyte lysate had a T3-binding affinity of 2.4 +/- 0.9 x 10(10) M-1 compared to the wild-type human placental receptor affinity of 5.2 +/- 1.6 x 10(10) M-1. Affected members of this kindred appeared clinically to have a relatively mild degree of resistance with mean total thyroxine of only 192 +/- 24 nmol/L and inappropriately normal TSH levels. Kindred CL is an example of mild generalized resistance to thyroid hormones correlated with a mutation in the beta-receptor that resulted in only a modest deficiency in T3-binding activity.

摘要

全身性甲状腺激素抵抗源于甲状腺激素受体c-erbAβ的T3结合结构域中的多种突变,不同家族具有不同的表型。然而,与野生型相比,这些在体外研究的突变受体的T3结合亲和力均显著降低。我们在此报告一个新家族CL,其突变位置比先前报道的更靠上游,密码子315中第1244位核苷酸的鸟嘌呤到腺嘌呤碱基替换,导致精氨酸变为组氨酸。该碱基替换是基因组序列密码子90 - 456中唯一发现的,通过筛查51名随机个体正式证明这是一种突变。重新构建了家族CL受体互补DNA,用兔网织红细胞裂解物合成的突变受体的T3结合亲和力为2.4±0.9×10(10)M-1,而野生型人胎盘受体亲和力为5.2±1.6×10(10)M-1。该家族的受累成员临床症状显示出相对轻度的抵抗,平均总甲状腺素仅为192±24 nmol/L,促甲状腺激素水平却异常正常。家族CL是轻度全身性甲状腺激素抵抗的一个例子,与β受体突变相关,该突变仅导致T3结合活性适度缺乏。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验